“The AFCP 2.0 program was extremely popular…. If administered correctly, another after-final program could provide tremendous benefit again, particularly to small and medium-sized entities.” As John ...
A private business has helped supercharge a controversial federal drug program. Patients and insurers have been left with big bills. By Ellen Gabler Soon after being diagnosed with metastatic breast ...